A
RCKT icon

AlphaQuest’s Rocket Pharmaceuticals RCKT Stock Holding History

AlphaQuest’s Portfolio RCKT Stock Details RCKT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-28,236
Closed -$99.1K – 1605
2025
Q4 		$99.1K Hold
28,236
– – 0.01% 1747
2025
Q3 		$92K Hold
28,236
– – 0.01% 1755
2025
Q2 		$69.2K Sell
28,236
-68,155
-71% -$345K 0.01% 1543
2025
Q1 		$643K Buy
96,391
+74,705
+344% +$738K 0.07% 437
2024
Q4 		$273K Buy
+21,686
New +$326K 0.04% 744
2024
Q2 		– Sell
-6,180
Closed -$166K – 1829
2024
Q1 		$166K Buy
+6,180
New +$176K 0.03% 698

Other funds holding RCKT

RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
MC
Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return
NM
Newtyn Management New York $801M AUM 23.14% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

AlphaQuest's RCKT Position: Q1 2026 in Review

AlphaQuest sold out of Rocket Pharmaceuticals (RCKT) in Q1 2026, closing a stake of 28,236 shares — an estimated $99.1K sold.

AlphaQuest first reported a position in RCKT in Q1 2024 and held it in 6 quarters. The position peaked at $643K in Q1 2025. 199 funds tracked by Wall St. Rank hold RCKT as of Q1 2026.

  • AlphaQuest reported no remaining Rocket Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
  • AlphaQuest sold 28,236 Rocket Pharmaceuticals shares in Q1 2026, an estimated $99.1K.
  • AlphaQuest first reported a position in Rocket Pharmaceuticals in Q1 2024 and held it in 6 quarters.
  • AlphaQuest's Rocket Pharmaceuticals position peaked at $643K in Q1 2025.
  • 199 funds tracked by Wall St. Rank held Rocket Pharmaceuticals as of Q1 2026.

Based on AlphaQuest's 13F filing for Q1 2026.